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ABSTRACT 
 
The renal clearance and urinary excretion of ciprofloxacin were investigated in eight healthy female 
goats. In each animal, ciprofloxacin was administered intramuscularly at the rate of 5 mg/kg body weight. 
Following drug administration, blood and urine samples were collected at different time intervals and 
analyzed for ciprofloxacin and creatinine. High performance liquid chromatography (HPLC) was used to 
determine the drug concentration in the plasma and urine. The value of diuresis after single administration 
of ciprofloxacin was 0.073 ± 0.014 ml/min/kg. Mean (± SE) values for renal clearance of creatinine and 
ciprofloxacin were 1.870 ± 0.385 and 0.982 ± 0.166 ml/min/kg, respectively. The ratio between the renal 
clearance of ciprofloxacin and that of creatinine remained less than one, which was indicative of back 
diffusion. The mean (± SE) value for the cumulative percent of ciprofloxacin dose excreted at 10 hours 
following its intramuscular administration was 13.03 ± 2.07. Based on these results, it was evident that 
besides glomerular filtration, renal handling of drug involved back diffusion also. It was concluded that in 
local goats glomerular filtration rate (GFR) was lower than that reported for their foreign counterparts. 
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INTRODUCTION 
 
Several studies have shown that the 
pharmacokinetic behavior, optimal dosage, renal 
clearance and urinary excretion of various drugs are 
different under indigenous conditions when compared 
with the values given in the literature or in the product 
inserts supplied by the manufacturers (Nawaz et al., 
1988; Muhammad, 1997; Javed et al. 2003; Javed et al. 
2005 a and b).   
The fluoroquinolones are a series of synthetic 
antibacterial agents which are used for the treatment of a 
variety of bacterial infections. All the fluoroqui-nolones 
exhibit such distributional and antimicrobial properties 
that make them potentially useful in veterinary 
medicine. They have extensive application in clinical 
practices because of their good bioavailability and 
pharmacokinetic profile, arousing great interest in the 
field of chemotherapy (Vancutsem et al., 1990). 
Ciprofloxacin is an important member of 
fluoroquinolone group of antibiotics. It is a broad 
spectrum antibiotic, being used to combat various 
infectious diseases in man and animals (Stein, 1996). 
However, biodisposition of ciprofloxacin has not been 
studied in local ruminant species. Keeping in view the 
vast clinical use of ciprofloxacin in local animals, the 
present study was designed to determine the renal 
clearance and urinary excretion of this drug in goats.  
MATERIALS AND METHODS 
 
Experimental animals and treatments  
Renal clearance and urinary excretion of 
ciprofloxacin was investigated in eight healthy adult 
female goats during the month of December, 2006. The 
average body weight of the goats was 35.38 + 1.97 kg. 
All the goats were maintained under similar 
environmental and managemental conditions at the 
Experimental Farm, Department of Livestock 
Management, University of Agriculture, Faisalabad, 
Pakistan. The animals were fed with seasonal green 
fodder and had free access to drinking water.  
In all animals, control blood and urine samples were 
collected before the drug administration. A commercial 
injectable preparation of ciprofloxacin (CIPROCIN-
100
®, Han Dong Corporation Ltd., Korea) was given 
intramuscularly at the rate of 5 mg/kg body weight to 
each animal. Following drug administration, the blood 
samples were collected at 1.0, 1.5, 2.0 and 2.5 hours in 
plastic centrifuge tubes. The pH of fresh blood samples 
was recorded using an electronic pH meter (Beckman 
HS, Germany) with a glass electrode at 37
0C. Blood 
samples were centrifuged, plasma was separated and 
stored at -20
0C until analysis.  
 
Renal clearance 
The left jugular vein of each goat was cannulated 
with a plastic canula (No. 90, Protex Ltd., England). 
Sterilized disposable balloon catheter (Rush No. 14, 30 
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ml) was inserted into urinary bladder through urethra of 
each animal after lubrication with paraffin gel. The 
external opening of catheter was connected through 
rubber tubing to a reservoir in which all the voided urine 
was quantitatively collected.  
  At 45 minutes following drug administration, the 
urinary bladder was emptied completely and washed 
with distilled water through the catheter. After washing, 
urine samples were collected at 75, 105, 135 and 165 
minutes after drug administration. The volume of each 
urine sample was measured. Ciprofloxacin 
concentrations in plasma and urine samples collected at 
different time intervals post medication were determined 
by using HPLC. The creatinine concentrations in plasma 
and urine samples were determined by using reagent kit 
(Thomas, 1998), with the help of BTS-330 (Bio-
Systems S.A., Spain) according to Jaffe reaction. Renal 
clearance of ciprofloxacin and endogenous creatinine 
was calculated. The renal clearance of endogenous 
creatinine was used for the estimation of glomerular 
filtration rate (GFR).  
 
Urinary excretion 
  For the determination of urinary excretion of 
ciprofloxacin, the urine samples were collected for the 
drug assay before and at 4, 6, 8 and 10 hours interval 
after drug administration. The pH of all urine samples 
was recorded. Cumulative percent of the dose of 
ciprofloxacin in the urine until 10 hours following its 
intramuscular administration was calculated. 
 
HPLC analysis 
Chromatography was performed with a High 
Performance Liquid Chromatograph (Sykam, S-1122) and 
analytes were determined using UV/Vis detector (Sykam, 
S-3210). The output of the detector was monitored with 
computer software (Peak Simple Chromatography Data 
System, Buck Scientific Inc., East Norwalk). A stainless 
steel column packed with YMC pack A-312 (Thermo 
Hypersil-Keystone, BDS-C18 with 250 x 4.6 mm 
dimensions and 5µm particle size) was used. The column 
was protected with a pre-column (Guard-Pak™) filled 
with a µBondapak™ C18 cartridge (Thermo Hypersil, 
England). Separation of ciprofloxacin was achieved at 
37
0C, using an isocratic mode. The mobile phase consisted 
of a mixture of 800 ml of 14 ml/L phosphoric acid and 200 
ml of acetonitrile per liter. The UV detector was set at 275 
nm and the flow rate was 1 ml/min.  
For preparation of plasma samples, 2 ml of 
acetonitrile was added to 1 ml of plasma, plasma blank or 
plasma calibrator in a centrifuge tube. The mixture was 
vortexed for one minute and centrifuged for 30 minutes at 
4000 rpm. The supernatant was transferred to a glass tube 
and the liquid phase was evaporated to dryness in a boiling 
water bath. The residue was then reconstituted in 10 µl of 
internal standard and 1 ml of 14 ml/L phosphoric acid. The 
final solution was again vortexed for 30 seconds, filtered 
and 20 µl was injected into the HPLC system. However, 
the urine samples were diluted 1:20 (by volume) with the 
mobile phase. In a centrifuge tube, 10 µl of the working 
solution of paracetamol was added to 1 ml of the diluted 
urine. The mixture was vortexed, filtered and 20 µl was 
injected directly into the HPLC system. This method, 
previously described by Soback et al. (1994), was partially 
modified and validated. The ciprofloxacin recovery was 
76% and coefficient of variation was <2% for intra and 
inter assays differences. The limit of detection was 75 
ng/ml, while the limit of quantitation was 250 ng/ml. 
 
Statistical analysis 
The mean (± SE) values for concentration of each 
metabolite were calculated. For the assessment of renal 
handling of ciprofloxacin following its intramuscular 
administration, influence of urine pH, rate of urine flow 
(diuresis) and plasma drug concentration on its renal 
clearance was examined by regression/correlation 
analysis using Microsoft Excel version, 2003. 
 
RESULTS AND DISCUSSION 
 
Renal clearance 
  The results of diuresis, blood and urine pH, renal 
clearance of creatinine and ciprofloxacin are presented 
in Table 1. The rate of urine flow (diuresis) in 8 goats 
following ciprofloxacin administration was 0.073 ± 
0.014 ml/min/kg. In previous studies on Danish goats, 
the value of diuresis was 0.052 ml/min/kg (Rasmussen 
et al., 1975), 0.049 ml/min/kg (Nawaz and Rasmussen, 
1979), in Pakistani goats 0.026 ml/min/kg (Shah et al., 
1983), 0.084 ml/min/kg (Javed et al., 1984), 0.130 
ml/min/kg (Iqbal et al., 1986), 0.052 ml/min/kg (Nawaz 
et al., 1990) and 0.121 ± 0.015 ml/min/kg (Iqbal, 1994). 
The rate of urine flow depends upon several factors like 
water intake, metabolic status of animal and environ- 
mental conditions. 
  The mean (± SE) value for the pH of blood was 
7.29 ± 0.02, while that of the urine it was 8.18 ± 0.01. 
The value of blood pH is within the range of values 
recorded in domestic ruminants including goats (Iqbal et 
al., 1986; Nawaz et al., 1988; Nawaz et al., 1990; Javed 
et al., 2005b). The distribution of a drug across 
biological membranes of various body compartments is 
determined by the physicochemical characteristics of the 
drug and pH of environment across the biomembrane 
(Baggot, 1977). The unionized moiety of  
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the drug can diffuse through biomembrane with ease and 
at equilibrium its concentration is alike on either side of 
the membrane. For acidic drugs, ionized moiety should 
be higher in the basic media or side of higher pH value. 
Thus, with decreasing alkaline pH, ionized moiety of the 
acidic drug would decrease, showing partly attribution 
to suitability for absorption.   
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  The goats used in the present study showed a mean 
value of 1.87 ± 0.385 ml/min/kg for the renal clearance 
of endogenous creatinine. This value was lower than 
2.62 ml/min/kg in Danish goats (Atef and Rasmussen, 
1975), 2.5 ml/min/kg (Rasmussen et al., 1975) and 2.15 
ml/min/kg (Nawaz and Rasmussen, 1979). However, 
this value was comparable to the values recorded in 
local goats i.e. 1.75 ml/min/kg (Shah et al., 1983), 1.11 
ml/min/kg (Javed et al., 1984), 1.43 and 1.86 ml/min/kg 
during summer and winter, respectively (Nawaz et al., 
1988), 1.62 ml/min/kg (Nawaz et al., 1990), 1.22 
ml/min/kg (Raoof, 1989) and 1.29 ml/min/kg (Iqbal, 
1994). These results indicate that GFR in local goats is 
lower than that in their foreign counterparts.  
  Mean (± SE) values for renal clearance of creatinine 
and ciprofloxacin were 1.870 ± 0.385 and 0.982 ± 0.166 
ml/min/kg, respectively. The ratio between the renal 
clearance of ciprofloxacin and that of creatinine 
remained less than one, which was indicative of back 
diffusion.  
  The analysis of data on diuresis, urine pH, plasma 
concentration of ciprofloxacin and renal clearance of 
endogenous creatinine and ciprofloxacin showed a 
significant (P<0.05) positive correlation (r = 0.420) 
between diuresis and renal clearance of the drug which 
is indicative of the back diffusion (Fig 1). However, 
plasma concentration of ciprofloxacin and urine pH did 
not influence the renal excretion of the drug. Hence, 
renal handling of ciprofloxacin in goats involved 
glomerular filtration and back diffusion. However, in 
rabbits, dogs and humans, although active tubular 
secretion was involved, yet the renal clearance of 
quinolonecarboxylic acid mostly took place through 
glomerular filtration (Shimada et al., 1983). 
 
Urinary excretion 
  Mean (± SE) values of urinary excretion in terms of 
cumulative percent of ciprofloxacin dose excreted in the 
urine at 4, 6, 8 and 10 hours following intramuscular 
administration have been presented in Fig 2. At 10 hours 
post drug administration, the value for the cumulative 
percent of ciprofloxacin dose excreted in the urine was 
13.03 ± 2.07. 
  About 40% of the intravenous dose of norfloxacin 
was reported to be recovered in the urine of donkeys   
 
Fig. 1: Effect of diuresis of ciprofloxacin on its renal 
clearance in goats. Each data point shows one 
of the 32 observations in 8 experiments, each 
comprised of 4 experimental periods. 
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Fig. 2: Mean (± SE) values for cumulative percent-
age of ciprofloxacin intramuscular dose (5 
mg/kg) excreted in urine of 8 goats at 
different time intervals. 
 
(Lavy et al., 1995). As reported by Montay et al. (1984), 
the urinary recovery of pefloxacin was 29% of its dose 
in mice, 37.8% in rats, 36.3% in dogs, 26.5% in 
monkeys and 58.9% in humans. Lower urinary excretion 
of ciprofloxacin in goats may be related to its renal 
handling. In goats regardless of the glomerular filtration, 
the administered dose of ciprofloxacin was also 
absorbed at kidney tubular level through back   
diffusion. Moreover, lower GFR in goats may be 
responsible for the lower urinary excretion of this drug.  
(Hasan, 1998). Since ciprofloxacin is zwitterions at   
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physiological pH, the pKa values have been reported as  
6.1 and 7.8 at its carboxylic and amino groups, 
respectively. It is at isoelectric point that ciprofloxacin is 
most lipophillic (Takacs-Novak et al., 1992). 
Considering ciprofloxacin as weakly basic drug with 
pKa value of 7.8, 50% of the drug would be unionized at 
pH 7.8. The unionization of the drug would increase 
with increase in the pH of urine in domestic ruminants. 
A high degree of unionization provides more drug 
available for reabsorption and therefore, high clearance 
values may not be observed when pH of urine is high 
and this correlates with the lower urinary excretion in 
the present study. 
 
Conclusions 
  Based on the findings of the present study, it was 
concluded that renal handling of ciprofloxacin, besides 
glomerular filtration, involved back diffusion also. 
Moreover, lower urinary excretion of ciprofloxacin was 
attributed to lower GFR and back diffusion at the kidney 
tubular level. 
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